THIS EXAMPLE IS UNDER RE-CONSTRUCTION FOLLOWING THE TEAM CALL ON 17 JAN. See also example in the "sandbox' here, which demonstrates the current approach reviewed on that call.
NOTE TO TEAM REVIEWERS:
The example below demonstrates the required data structure of one record per analyte per replicate per test condition per timepoint to accurately represent data from a stability study. The resulting structure would require 648 rows to illustrate the 12 analytes shown in the example study we received, done in triplicate under two test conditions at the number of timepoints in the example study.
For conciseness, we have abbreviated the examples below to demonstrate the concepts as follows:
First- we show all 12 analytes as a single replicate, at one time point and one test condition in order to illustrate the variables and terminology required to put together a stability study with assays done in replicate at different time points and varying test conditions, even though only one record per analyte is illustrated.
Second- We show ONE analyte (moisture) in triplicate, over a series of time points and two test conditions to give a sense of what the complete data would look like.
Hopefully users could combine the information shown in both examples to construct a complete dataset containing all the records for each analyte-replicate-test condition-time point group.
The example shown below is not an all inclusive comprehensive example. It is meant to be illustrative of the concepts.
Shelf life study has a protocol and provides the results of shelf life studies of Vapes products over time with different conditions and analytes. Generally there are many conditions with at least two with varying temperature, humidity, etc. The initial table shows the a number of the analytes and test conditions used in Shelf Life studies for Vapes products for one testing condition at one timepoint and one replicate.
Tobacco Product Testing (PT) is a Findings domain similar to the Laboratory Test Results domain.
PTCAS variable (in place of the LBLOINC variable) provides the accurate chemical name, structure for organic and inorganic substances.
Question: For laboratory's limit of detection (LOD), limit of quantification (LOQ); Should we have --ORNRLO = Reference Range Lower Limit in Orig Unit; and --ORNRHI = Reference Range Upper Limit in Orig Unit? There is a variable --LLOD = Lower Limit of Detection. Added this for LOD. What should be used for LOQ? Thanks.
Rows 1-20:
Show several analytes (as noted in the PTTEST) in the E-Liquid substance for the condition noted in PTTSTCND which is Condition 1.
Rows 2, 12, 13:
Show the Nicotine, 4-(N-methyl-N-nitrosoamino)-1-(3-pyridyl)-1-butanone (NNK), and N-nitrosonornicotine analytes in the Aerosol substance represented using the PTSPEC variable.
Rows 17, 18:
Show microbials, TAMC and TYMC (PTTEST and PTTESTCD), used in testing (aerobic plate count, mold, and yeast) using the PTSCAT variable. The E-Liquid substance has the condition represented using the PTTSTCND which is Condition 1.
pt.xpt
pt.xpt
Row
STUDYID
DOMAIN
SPTOBID
SPDEVID
STOCONDID
PTSEQ
PTREFID
PTTESTCD
PTTEST
PTCAT
PTSCAT
PTORRES
PTORRESU
PTLLOD
PTSTRESC
PTSTRESN
PTSTRESU
PTSPEC
PTSPCCND
PTMETHOD
PTLLOQ
PTREPNUM
PTTPT
PTTPTNUM
1
TOB07
PT
111
Condition 1
1
VAP77777.1
NICOTINE
Nicotine
STABILITY STUDY
35.94
mg/g
35.94
35.94
mg/g
E-LIQUID
1
Week 0
1
2
TOB07
PT
111
Condition 1
2
VAP77777.1
NICOTINE
Nicotine
STABILITY STUDY
0.1039
mg/PUFF
0.1039
0.1039
mg/PUFF
AEROSOL
1
Week 0
1
3
TOB07
PT
111
Condition 1
3
VAP77777.1
NORNCTN
Nornicotine
STABILITY STUDY
Nicotine Degradant
25.76
ug/g
25.76
25.76
ug/g
E-LIQUID
1
Week 0
1
4
TOB07
PT
111
Condition 1
3
VAP77777.1
NORNCTN
Nornicotine
STABILITY STUDY
Nicotine Degradant
0.0392
ug/PUFF
0.0392
0.0392
ug/PUFF
AEROSOL
1
Week 0
1
5
TOB07
PT
111
Condition 1
5
VAP77777.1
GLYCRL
Glycerol
STABILITY STUDY
Primary Ingredient
615.68
mg/g
615.68
615.68
mg/g
E-LIQUID
1
Week 0
1
6
TOB07
PT
111
Condition 1
5
VAP77777.1
GLYCRL
Glycerol
STABILITY STUDY
Primary Ingredient
1.81
mg/PUFF
0.00144
1.81
1.81
mg/PUFF
AEROSOL
1
Week 0
1
7
TOB07
PT
111
Condition 1
6
VAP77777.1
PRPYLGLY
Propylene Glycol
STABILITY STUDY
Primary Ingredient
218.21
mg/g
218.21
218.21
mg/g
E-LIQUID
1
Week 0
1
8
TOB07
PT
111
Condition 1
6
VAP77777.1
PRPYLGLY
Propylene Glycol
STABILITY STUDY
Primary Ingredient
0.8565
mg/PUFF
0.00024
0.8565
0.8565
mg/PUFF
AEROSOL
1
Week 0
1
9
TOB07
PT
111
Condition 1
7
VAP77777.1
BNZOICAC
Benzoic Acid
STABILITY STUDY
Acid
E-LIQUID
1
Week 0
1
10
TOB07
PT
111
Condition 1
8
VAP77777.1
MENTHOL
Menthol
STABILITY STUDY
Flavorant
37.53
mg/g
37.53
37.53
mg/g
E-LIQUID
1
Week 0
1
11
TOB07
PT
111
Condition 1
8
VAP77777.1
MENTHOL
Menthol
STABILITY STUDY
Flavorant
0.5881
mg/PUFF
0.00024
0.5881
0.5881
mg/PUFF
AEROSOL
1
Week 0
1
12
TOB07
PT
111
Condition 1
VAP77777.1
GLYCDOL
Glycidol
STABILITY STUDY
Stabilizer
<Limit of Detection (LOD)
0.00011
<Limit of detection (LOD)
AEROSOL
1
Week 0
1
13
TOB07
PT
111
Condition 1
VAP77777.1
FRMLDHD
Formaldehyde
STABILITY STUDY
0.0728
ug/PUFF
0.00549
0.0728
0.0728
ug/PUFF
AEROSOL
1
Week 0
1
14
TOB07
PT
111
Condition 1
VAP77777.1
ACROLN
Acrolien
STABILITY STUDY
<Limit of Quantification (LOQ)
0.00928
Limit of Quantification (LOQ)
AEROSOL
1
Week 0
1
15
TOB07
PT
111
Condition 1
VAP77777.1
LACTICAC
Lactic Acid
STABILITY STUDY
40.44
ug/g
40.44
40.44
ug/g
E-LIQUID
1
Week 0
1
16
TOB07
PT
111
Condition 1
VAP77777.1
LACTICAC
Lactic Acid
STABILITY STUDY
29.71
ug/PUFF
0.284
29.71
29.71
ug/PUFF
AEROSOL
1
Week 0
1
17
TOB07
PT
111
Condition 1
9
VAP77777.1
VANLLN
Vanillin
STABILITY STUDY
Flavorant
1.12
ug/g
1.12
1.12
ug/g
E-LIQUID
1
Week 0
1
18
TOB07
PT
111
Condition 1
10
VAP77777.1
NNK
Nicotine-Derived Nitrosamine Ketone
STABILITY STUDY
HPHC
0.0711
ug/g
0.0711
0.0711
ug/g
E-LIQUID
1
Week 0
1
19
TOB07
PT
111
Condition 1
11
VAP77777.1
NNN
N-Nitrosonornicotine
STABILITY STUDY
HPHC
0.0852
ug/g
0.0852
0.0852
ug/g
E-LIQUID
1
Week 0
1
20
TOB07
PT
111
Condition 1
12
VAP77777.1
NNK
Nicotine-Derived Nitrosamine Ketone
STABILITY STUDY
HPHC
0.0577
ug/PUFF
0.0577
0.0577
ug/PUFF
AEROSOL
1
Week 0
1
21
TOB07
PT
111
Condition 1
13
VAP77777.1
NNN
N-Nitrosonornicotine
STABILITY STUDY
HPHC
0.0742
ug/PUFF
0.0742
0.0742
ug/PUFF
AEROSOL
1
Week 0
1
22
TOB07
PT
111
Condition 1
14
VAP77777.1
NICKEL
Nickel
STABILITY STUDY
Extractables / Leachables
0.0897
ug/g
0.0897
0.0897
ug/g
E-LIQUID
1
Week 0
1
23
TOB07
PT
111
Condition 1
14
VAP77777.1
MASS
Mass
STABILITY STUDY
3.87
mg/PUFF
0.0071
3.87
3.87
mg/PUFF
AEROSOL
1
Week 0
1
24
TOB07
PT
111
Condition 1
14
VAP77777.1
CHROMIUM
Chromium
STABILITY STUDY
NOT DETECTED
NOT DETECTED
E-LIQUID
1
Week 0
1
25
TOB07
PT
111
Condition 1
15
VAP77777.1
PH
pH
STABILITY STUDY
7.15
7.15
7.15
E-LIQUID
1
Week 0
1
26
TOB07
PT
111
Condition 1
15
VAP77777.1
PH
pH
STABILITY STUDY
7.24
7.24
7.24
AEROSOL
1
Week 0
1
27
TOB07
PT
111
Condition 1
16
VAP77777.1
ENDTXN
Endotoxin
STABILITY STUDY
Toxins
E-LIQUID
1
Week 0
1
28
TOB07
PT
111
Condition 1
17
VAP77777.1
AEBPLCT
Aerobic Plate Count
STABILITY STUDY
Microbiological
<1
CFU/mL
<1
<1
CFU/mL
E-LIQUID
1
Week 0
1
29
TOB07
PT
111
Condition 1
18
VAP77777.1
TYMC
Total Yeast and/or Mold Count
STABILITY STUDY
Microbiological
1
CFU/mL
1
1
CFU/mL
E-LIQUID
1
Week 0
1
30
TOB07
PT
111
Condition 1
19
VAP77777.1
ACTALD
Acetaldehyde
STABILITY STUDY
Aldehyde
E-LIQUID
1
Week 0
1
31
TOB07
PT
111
Condition 1
20
VAP77777.1
ACTPROPN
Acetyl Propionyl
STABILITY STUDY
Diketone
E-LIQUID
1
Week 0
1
Dataset Debug Messages
There are four leading, trailing, or non-breaking spaces in the dataset.
A Shelf Life study dataset would shows analytes done in different test conditions with replicates over time points. In the interest of brevity for this example, only portions of the content using the TEST of Nicotine is shown in a sample of timepoints in two conditions with replicates. The weeks reflective of Week 1, Week 2, Week 3, etc. which would align with the PTTPTNUM of 2,3, etc. are not shown for visual viewing purposes. This is an example, this provides possible tests that might be used to demonstrate how to use the datasets and variables to show what was done for the shelf-life stability study. It shows what timepoint and what type of data follows. It is important to show different test conditions for each analyte. For aerosol a machine similutaion is use so mg/puff is valid.
Rows 1-9:
Show the PTTEST of Nicotine for Condition 1 which is shown in PTTSTCND. The sample of various timepoints that may be used in the testing for Nicotine is reflected in PTTPT. The PTTPTNUM shows the numerical version of the planned timepoint. The REPNUM shows the incidence number of a test that is repeated within a given timeframe for the same test.
Rows 10-19:
Show the PTTEST of Nicotine for Condition 2 across the same timepoints. The PTGRPID is used to tie together a block of related records in a single domain.
Rows 20-27:
Show the PTTEST of Nicotine for Condition 3 across the same timepoints. The PTGRPID is used to tie together a block of related records in a single domain.
pt.xpt
pt.xpt
Row
STUDYID
DOMAIN
SPTOBID
STOCONID
PTSEQ
PTREFID
PTGRPID
PTTESTCD
PTTEST
PTORRES
PTORRESU
PTSTRESC
PTSTRESN
PTSTRESU
PTSPEC
PTSPCCND
PTMETHOD
PTREPNUM
PTTPT
PTTPTNUM
1
TOB07
PT
111
Condition 1
211
VAP77777.1
1
NICOTINE
Nicotine
35.94
mg/g
35.94
35.94
mg/g
E-LIQUID
1
Week 0
1
2
TOB07
PT
111
Condition 1
212
VAP77777.1
1
NICOTINE
Nicotine
35.46
mg/g
35.46
35.46
mg/g
E-LIQUID
2
Week 0
1
3
TOB07
PT
111
Condition 1
213
VAP77777.1
1
NICOTINE
Nicotine
35.97
mg/g
35.97
35.97
mg/g
E-LIQUID
3
Week 0
1
4
TOB07
PT
111
Condition 1
214
VAP77777.1
1
NICOTINE
Nicotine
35.55
mg/g
35.55
35.55
mg/g
E-LIQUID
1
Week 24
4
5
TOB07
PT
111
Condition 1
215
VAP77777.1
1
NICOTINE
Nicotine
35.88
mg/g
35.88
35.88
mg/g
E-LIQUID
2
Week 24
4
6
TOB07
PT
111
Condition 1
216
VAP77777.1
1
NICOTINE
Nicotine
35.67
mg/g
35.67
35.67
mg/g
E-LIQUID
3
Week 24
4
7
TOB07
PT
111
Condition 1
217
VAP77777.1
1
NICOTINE
Nicotine
36.11
mg/g
36.11
36.11
mg/g
E-LIQUID
1
Week 52
9
8
TOB07
PT
111
Condition 1
218
VAP77777.1
1
NICOTINE
Nicotine
35.72
mg/g
35.72
35.72
mg/g
E-LIQUID
2
Week 52
9
9
TOB07
PT
111
Condition 1
219
VAP77777.1
1
NICOTINE
Nicotine
35.54
mg/g
35.54
35.54
mg/g
E-LIQUID
3
Week 52
9
10
TOB07
PT
111
Condition 2
220
VAP77777.1
3
NICOTINE
Nicotine
0.1039
mg/PUFF
0.1039
0.1039
mg/puff
AEROSOL
1
Week 0
1
11
TOB07
PT
111
Condition 2
221
VAP77777.1
3
NICOTINE
Nicotine
0.1142
mg/PUFF
0.1142
0.1142
mg/puff
AEROSOL
2
Week 0
1
12
TOB07
PT
111
Condition 2
222
VAP77777.1
3
NICOTINE
Nicotine
0.1282
mg/PUFF
0.1282
0.1282
mg/puff
AEROSOL
3
Week 0
1
13
TOB07
PT
111
Condition 2
223
VAP77777.1
3
NICOTINE
Nicotine
0.1242
mg/PUFF
0.1242
0.1242
mg/puff
AEROSOL
1
Week 24
4
14
TOB07
PT
111
Condition 2
224
VAP77777.1
3
NICOTINE
Nicotine
0.1084
mg/PUFF
0.1084
0.1084
mg/puff
AEROSOL
2
Week 24
4
15
TOB07
PT
111
Condition 2
225
VAP77777.1
3
NICOTINE
Nicotine
0.1174
mg/PUFF
0.1174
0.1174
mg/puff
AEROSOL
3
Week 24
4
16
TOB07
PT
111
Condition 2
226
VAP77777.1
3
NICOTINE
Nicotine
0.1374
mg/PUFF
0.1374
0.1374
mg/puff
AEROSOL
1
Week 52
9
17
TOB07
PT
111
Condition 2
227
VAP77777.1
3
NICOTINE
Nicotine
0.1364
mg/PUFF
0.1364
0.1364
mg/puff
AEROSOL
2
Week 52
9
18
TOB07
PT
111
Condition 2
228
VAP77777.1
3
NICOTINE
Nicotine
0.1264
mg/PUFF
0.1264
0.1264
mg/puff
AEROSOL
3
Week 52
9
19
TOB07
PT
111
Condition 2
229
VAP77777.1
3
NICOTINE
Nicotine
0.1256
mg/PUFF
0.1256
0.1256
mg/puff
AEROSOL
1
Week 0
1
20
TOB07
PT
111
Condition 3
230
VAP77777.1
4
NICOTINE
Nicotine
0.1236
mg/PUFF
0.1236
0.1236
mg/puff
AEROSOL
2
Week 0
1
21
TOB07
PT
111
Condition 3
231
VAP77777.1
4
NICOTINE
Nicotine
0.1126
mg/PUFF
0.1126
0.1126
mg/puff
AEROSOL
3
Week 0
1
22
TOB07
PT
111
Condition 3
232
VAP77777.1
4
NICOTINE
Nicotine
0.1334
mg/PUFF
0.1334
0.1334
mg/puff
AEROSOL
1
Week 24
4
23
TOB07
PT
111
Condition 3
233
VAP77777.1
4
NICOTINE
Nicotine
0.1134
mg/PUFF
0.1134
0.1134
mg/puff
AEROSOL
2
Week 24
4
24
TOB07
PT
111
Condition 3
234
VAP77777.1
4
NICOTINE
Nicotine
0.1125
mg/PUFF
0.1125
0.1125
mg/puff
AEROSOL
3
Week 24
4
25
TOB07
PT
111
Condition 3
235
VAP77777.1
4
NICOTINE
Nicotine
0.1156
mg/PUFF
0.1156
0.1156
mg/puff
AEROSOL
1
Week 52
9
26
TOB07
PT
111
Condition 3
236
VAP77777.1
4
NICOTINE
Nicotine
0.1145
mg/PUFF
0.1145
0.1145
mg/puff
AEROSOL
2
Week 52
9
27
TOB07
PT
111
Condition 3
237
VAP77777.1
4
NICOTINE
Nicotine
0.1157
mg/PUFF
0.1157
0.1157
mg/puff
AEROSOL
3
Week 52
9
$warningHtml
Dataset Wrapper Debug Message
Please add a row column to your dataset.
Details of the storage conditions are represented in the Environmental Storage Conditions (ES) dataset. The variable STOCONID/Storage Condition ID represents the storage condition. Each of the parameters defining that storage condition are represented in ESPARMCD/ESPARM, with values and units shown in ESVAL/ESVALU.